eFFECTOR Therapeutics, Inc. (EFTR) Social Stream
EFFECTOR THERAPEUTICS INC (EFTR) Price Targets From Analysts
Use the tables below to see what analysts covering EFFECTOR THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 4 | $50 | $20 | $30.75 | $0.531 | 5690.96% |
| 2022-01-25 | 4 | $50 | $6.2 | $27.3 | $0.531 | 5041.24% |
| 2022-05-11 | 4 | $50 | $3.4 | $26.6 | $0.531 | 4909.42% |
| 2022-08-11 | 4 | $10 | $3.4 | $6.133 | $0.531 | 1054.99% |
| 2022-11-08 | 3 | $10 | $3 | $6 | $0.531 | 1029.94% |
| 2022-11-17 | 3 | $10 | $2 | $5 | $0.531 | 841.62% |
| 2023-03-09 | 3 | $10 | $1 | $4.1 | $0.531 | 672.13% |
| 2023-05-11 | 4 | $10 | $1 | $4.825 | $0.531 | 808.66% |
| 2023-06-05 | 4 | $10 | $1 | $6.25 | $0.531 | 1077.02% |
| 2023-08-09 | 4 | $10 | $1 | $5.85 | $0.531 | 1001.69% |
| 2023-08-24 | 4 | $7 | $1 | $4.6 | $0.531 | 766.29% |
| 2023-11-13 | 3 | $7 | $5 | $5.8 | $0.531 | 992.28% |
The Trend in the Analyst Price Target
Over the past 44 weeks, EFTR's average price target has gone up $1.7.
Over the past 44 weeks, EFTR's average upside potential has been 733.27%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-11 | 4 | 10 | 1 | 4.825 | 0.542 | 790.22% |
| 2023-08-24 | 3 | 7 | 1 | 4.600 | 0.720 | 538.89% |
| 2023-08-24 | 4 | 7 | 5 | 5.800 | 0.720 | 705.56% |
| 2023-08-24 | 5 | 10 | 1 | 5.680 | 0.720 | 688.89% |
| 2023-08-24 | 5 | 7 | 5 | 5.800 | 0.720 | 705.56% |
EFTR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
EFTR's average broker recommendation rating improved by 0.67 over the prior 43 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- EFTR has a greater upside potential (average analyst target price relative to current price) than 1757.82% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, EFFECTOR THERAPEUTICS INC's variance in analysts' estimates is lower than -1563.14% of them.
- EFFECTOR THERAPEUTICS INC's number of analysts covering the stock is higher than 262.83% of Healthcare stocks.
- EFTR has a greater average analyst price target than 322.52% of Healthcare stocks.
In the Pharmaceutical Products industry, BOLT, TERN, and ADAG are the three stocks most similar to EFFECTOR THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding EFTR using the data that counts. Try POWR Ratings for free.